Trials / Unknown
UnknownNCT03000049
Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- University Medicine Greifswald · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobial therapy in patients with sepsis and septic shock. Prospective observational, open-label mono-center study to compare a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System and Curetis Univero System) with standard blood culture diagnostics in patients with sepsis or septic shock.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | bedside blood culture |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-07-01
- Completion
- 2017-09-01
- First posted
- 2016-12-21
- Last updated
- 2016-12-22
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03000049. Inclusion in this directory is not an endorsement.